A comparative analysis of bilateral subcapsular orchidectomy and bilateral total orchidectomy in evaluating castration timeline in prostate cancer subjects
Phase 3
Not yet recruiting
- Conditions
- Urological and Genital DiseasesCancerSurgery
- Registration Number
- PACTR202311880225067
- Lead Sponsor
- ELIBOH MONDAY
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Male
- Target Recruitment
- 66
Inclusion Criteria
Patient with clinical, laboratory and radiologic features and histologically diagnosed prostate cancer
Exclusion Criteria
Patients with no histopathologic confirmation of prostate cancer.
Patients with prostate cancer who are on any form of prostate cancer androgen ablation therapy (GnRH agonist, stilboestrol, or antiandrogen).
Patients with chronic liver disease.
Any patient with clinical ultrasonic or radiologic features of tumour other than prostate cancer
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method